Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD Randomized Clinical Trial
Research suggests Medicare could spend $65.9 billion for GLP-1s over the next 10 years
Explore Empire's hands-on, CME-accredited Medical Weight Loss & Metabolic Health courses live patients, expert faculty, and ongoing mentorship
Intramuscular (IM) injections are common for routine repletion of B levels, whereas intravenous (IV) administration might be used in emergency situations or when large doses are required quickly
Such widespread usage has led to a severe and prolonged international shortage of these drugs 13,14 , with consequent lack of access to treatment for patients with diabetes 15 and the urgent need to issue guidelines for alternative treatments 16
WEIGHT EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 Exogenous GLP-1 was soon demonstrated to have other effects of interest in relation to T2DM, most importantly an inhibitory effect on appetite and food intake [9]